Hemolytiskt uremiskt syndrom och trombotisk trombocytopen purpura. Nya rön om EHEC, komplementmutationer och ADAMTS13

Lakartidningen

Volumn 105, Issue 15, 2008, Pages 1096-1101

  Karpman, Diana ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; BIOLOGICAL MARKER; COMPLEMENT;

ARTICLE; BLOOD; DIFFERENTIAL DIAGNOSIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENETICS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOLOGY; KIDNEY CORTEX; MUTATION; PATHOGENICITY; PATHOLOGY; RECURRENT DISEASE; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; BIOLOGICAL MARKERS; COMPLEMENT SYSTEM PROTEINS; DIAGNOSIS, DIFFERENTIAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY CORTEX; MUTATION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; THROMBOSIS;

EID: 42649137892     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Karpman D. Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Curr Paediatrics. 2002;12:569-74.
2. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. A classification of haemolytic uremic syndrome, thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423-31.
3. Kavanagh D, Goodship TH, Richards A. Atypical haemolytic uraemic syndrome. Br Med Bull. 2006;77-78:5-22.
4. Karpman D, Blom A, Goodship T, Sullivan KE. Anguish over angiopathy: hemolytic uremic syndrome. Clin Immunol. 2007;122:135-8.
5. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med. 1998;339(22):1578-84.
6. Griffin PM. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Cuerrant RI, editors. Infections of the gastrointestinal tract. New York: Raven Press Ltd; 1995. p. 739-61.
7. Sartz L, Plym-Forshell L, de Jong B, Hjertqvist M, Alsterlund R, Löfdahl S, et al. An outbreak of Escherichia coli O157:H7 infection in southern Sweden associated with intake of fermented sausage; aspects of sausage production increase the risk of contamination. Epidemiol Infect. 2007;20:1-11.
8. Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr. 2007;151(2):140-4.
9. Moake JL. Thrombotic microangiopathies [review]. N Engl J Med. 2002;347(8):589-600.
10. Manea M, Kristoffersson AC, Schneppenheim R, Saleem MA, Mathieson PW, Mörgelin M, et al. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br J Haematol. 2007;138:651-62.
11. Proulx F, Seidman E, Karpman D. The pathogenesis of diarrhea associated hemolytic uremic syndrome. Pediatr Res. 2001;50:163-71.
12. Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Johnson R, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood. 2006;108:167-76.
13. Karpman D, Papadopoulou D, Nilsson K, Sjögren AC, Mikaelsson C, Lethagen S. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood. 2001;97:3100-8.
14. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(2):555-63.
15. Vaziri-Sani F, Hellwage J, Zipfel PF, Sjoholm AG, Iancu R, Karpman D. Factor H binds to washed human platelets. J Thromb Haemost. 2005;3(1):154-62.
16. Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, et al. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol. 2007;44(8):1835-44.
17. Sjögren AC, Kaper JB, Caprioli A, Karpman D. A diagnostic ELISA for the detection of Shiga toxin producing Escherichia coli infection by antibodies to E. coli secreted protein B in children with hemolytic uremic syndrome. Eur J Clin Microbiol Infect Dis. 2004;23:208-11.
18. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics. 2005;115(6):e673-80.
19. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342(26):1930-6..
20. Saland JM, Emre SH, Shneider BL, Benchimol C, Ames S, Bromberg JS, et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant. 2006;6(8):1948-52.